September 2017 Vol 10, No 6

Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide

Ajay S. Behl, PhD; Lorie A. Ellis, PhD; Dominic Pilon, MA; Yongling Xiao, PhD; Patrick Lefebvre, MA

Stakeholder Perspective

A First Step Toward Improving the Complex Approach to Metastatic Prostate Cancer Management

Gary M. Owens, MD

Clinical, Original Research

The Relative Burden of Menopausal and Postmenopausal Symptoms versus Other Major Conditions: A Retrospective Analysis of the Medical Expenditure Panel Survey Data

Annlouise R. Assaf, PhD; Andrew G. Bushmakin, MS; Nina Joyce, PhD; Michael J. Louie, MD, MPH, MSc; Michael Flores, MPH; Margaret Moffatt, MPH

Stakeholder Perspective

Hormone Therapy Remains Effective for Treating Menopausal Symptoms, May Save Overall Costs

JoAnn V. Pinkerton, MD, FACOG, NCMP

Editorial

Health Inequities in America

David B. Nash, MD, MBA

Business, Original Research

Costs and Effectiveness of Mindfulness-Based Art Therapy versus Standard Breast Cancer Support Group for Women with Cancer

Katherine M. Prioli, BS; Laura T. Pizzi, PharmD, MPH; Kathryn M. Kash, PhD; Andrew B. Newberg, MD; Anna Marie Morlino, PharmD; Michael J. Matthews, BS; Daniel A. Monti, MD

Stakeholder Perspective

Creative Therapeutic Activities and Support Groups Benefit All Those Involved in Cancer Care

Linda Bily, MA, CSA, OPN-CG

Results 1 - 4 of 4

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Special Print Editions

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.